サブ-ナビゲーション
  • ->TOP
  • News Release
  • Who we are
  • ”Hyaluronic Acid” Expedition
  • What is Glycoscience
  • Our R&D
  • Management Policy
  • Highlights
  • Stock Information
  • Investors
  • Our Company
  • Privacy Policy
  • Terms of Use
  • Sitemap

News Release

Seikagaku News Releases are issued to provide stakeholders with the most up-to-date information related to our company.

News Release

What's New

  • 07.31.2020 Seikagaku announced the financial results for the First Quarter of the Fiscal Year ending March 31, 2021

    読む Seikagaku announced the financial results for the First Quarter of the Fiscal Year ending March 31, 2021

  • 07.01.2020 Seikagaku will announce the financial results for the First Quarter of the Fiscal Year ending March 31, 2021 at 15:00 on July 31, 2020.

    読む Seikagaku will announce the financial results for the First Quarter of the Fiscal Year ending March 31, 2021 at 15:00 on July 31, 2020.

  • 06.19.2020 New Message from President & CEO

    読む New Message from President & CEO

  • 05.22.2020 Presentation Material for the Briefing on FY2019

    読む Presentation Material for the Briefing on FY2019

Who we are

More

What is Glycoscience

More

Our R&D

More

Bulk products

More

LAL
Reagents

More

Glyco
forum

More

This link will direct you to a third-party site.（Another window opens.）

Please click here

Step back to the Seikagaku Corporation website

The Seikagaku Corporation website uses cookies to personalize contents and offer a better browsing experience. Please click the Accept botton. （Read more）

Accept

生化学工業株式会社
  • 日本語
  • ”Hyaluronic Acid” Expedition
  • Contact Us　

Who we are

What is Glycoscience

What is Glycoscience

Are glucides sweet?

Glycoscience in one minute

Introduction to the Glycoscience

Glycoscience in one minute

Glycoscience in one minute

”Hyaluronic Acid” Expedition

”Hyaluronic Acid” Expedition

Our R&D

Our R&D

R&D Basic Policy

R&D Structure

R&D Pipeline

Process of new drug development

Intellectual Property

R&D Basic Policy

R&D Basic Policy

R&D Pipeline

R&D Pipeline

Investors

Investors

News Release

What's New

Management Policy

Highlights

IR Library

IR Schedule

Shareholder Information

IR E-mail Alert

Message from President & CEO

Message from President & CEO

Our Company

Our Company

Greeting

Corporate Philosophy

History

Corporate Profile

Member of the Board

Organizational Chart

Corporate Governance

Compliance

Value Creation Process

Social Contribution Activities

Business Activities

Corporate Philosophy

Corporate Philosophy

Business Activities

Business Activities
生化学工業株式会社

Who we are

What is Glycoscience

Are glucides sweet?

Glycoscience in one minute

Introduction to the Glycoscience

  • Part 1　Invitation to Glycoscience
  • Part 2　Fertilization
  • Part 3　Source of Energy
  • Part 4　Extracellular matrix 1
  • Part 5　Extracellular matrix 2
  • Part 6　Cell proliferation and differentiation
  • Part 7　Blood type
  • Part 8　Cancer
  • Part 9　Viral infection
  • Part 10　Applications and Developments

”Hyaluronic Acid” Expedition

Hyaluronic Acid - I am also in your home

Hyaluronic Acid- Everywhere in your body

Hyaluronic Acid- This is what I am!

Hyaluronic Acid- How I work in your body

Story Time

Our R&D

R&D Basic Policy

R&D Structure

R&D Pipeline

Process of new drug development

Intellectual Property

Investors

News Release

What's New

Management Policy

  • Message from President & CEO
  • Mid-term Management Plan
  • R&D Pipeline
  • Profit Distribution Policies
  • Business Risks

Highlights

  • Business Performance
  • Business Performance（Quarter）
  • Cash Flow
  • Business Performance Data Download

IR Library

  • Summary of Financial Results
  • Presentation Material
  • Corporate Report

IR Schedule

Shareholder Information

  • Stock Information
  • Shareholder Composition
  • Profit Distribution
  • General Meeting of Shareholders
  • Analyst Coverage
  • Stock Price

IR E-mail Alert

Our Company

Greeting

Corporate Philosophy

History

Corporate Profile

Member of the Board

Organizational Chart

Corporate Governance

Compliance

Value Creation Process

Social Contribution Activities

Business Activities

  • Business Segment
  • Products
    • Pharmaceuticals and Medical Devices
    • Bulk Products
      • Sodium Hyaluronate
      • Sodium Chondroitin Sulfate
    • Endotoxin-detecting reagents
    • Oral Care Product
  • Production
  • Quality Compliance
  • Contact Us
  • 日本語

Glycoscience for Human Well-being

Engaging in drug discovery as a pioneer of glycoscience

Glycoscience for Human Well-being

Engaging in drug discovery as a pioneer
of glycoscience

Glycoscience for Human Well-being

To help people around the world live healthy and rich lives

Glycoscience for Human Well-being

To help people around the world
live healthy and rich lives

Glycoscience for Human Well-being

Stable supply of high-quality pharmaceuticals
with a sense of mission and pride

Glycoscience for Human Well-being

Stable supply of high-quality pharmaceuticals
with a sense of mission and pride

To page top
To page top

Who we are

What is Glycoscience

Are glucides sweet?

Glycoscience in one minute

Introduction to the Glycoscience

”Hyaluronic Acid” Expedition

Hyaluronic Acid - I am also in your home

Hyaluronic Acid- Everywhere in your body

Hyaluronic Acid- This is what I am!

Hyaluronic Acid- How I work in your body

Story Time

Our R&D

R&D Basic Policy

R&D Structure

R&D Pipeline

Process of new drug development

Intellectual Property

Investors

News Release

What's New

Management Policy

Highlights

IR Library

IR Schedule

Shareholder Information

IR E-mail Alert

Our Company

Greeting

Corporate Philosophy

History

Corporate Profile

Member of the Board

Organizational Chart

Corporate Governance

Compliance

Value Creation Process

Social Contribution Activities

Business Activities

Copyright © SEIKAGAKU CORPORATION All rights Reserved.

  • Privacy Policy
  • Terms of Use